|
|||||
|
|
Phase I and pharmacokinetics/pharmacodynamics study of the MEK inhibitor RO4987655 in Japanese patients with advanced solid tumors |
|
| Authors: | Shinji Nakamichi Hiroshi Nokihara Noboru Yamamoto Yasuhide Yamada Yutaka Fujiwara Yosuke Tamura Hiroshi Wakui Kazunori Honda Hidenori Mizugaki Satoru Kitazono Yuko Tanabe Hajime Asahina Naoya Yamazaki Shigenobu Suzuki Mieko Matsuoka Yoshitaka Ogita Tomohide Tamura |
| Affiliation: | 1. Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan 2. Department of Gastrointestinal Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan 3. Department of Dermatological Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan 4. Department of Ophthalmic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan 5. Clinical Research Planning Department, Chugai Pharmaceutical Co., Ltd., 2-1-1 Nihonbashi-muromachi, Chuo-ku, Tokyo, Japan |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |